Finding new treatments for diabetes--how many, how fast... how good? - PubMed (original) (raw)

. 2007 Feb 1;356(5):437-40.

doi: 10.1056/NEJMp068294.

Affiliations

• PMID: 17267901
• DOI: 10.1056/NEJMp068294

Finding new treatments for diabetes--how many, how fast... how good?

David M Nathan. N Engl J Med. 2007.

No abstract available

PubMed Disclaimer

Comment in

• New treatments for diabetes.
  Bloomgarden ZT, Inzucchi SE. Bloomgarden ZT, et al. N Engl J Med. 2007 May 24;356(21):2219-20; author reply 2222-3. doi: 10.1056/NEJMc070546. N Engl J Med. 2007. PMID: 17522409 No abstract available.
• New treatments for diabetes.
  Mintz ML. Mintz ML. N Engl J Med. 2007 May 24;356(21):2221-2; author reply 2222-3. N Engl J Med. 2007. PMID: 17526094 No abstract available.
• New treatments for diabetes.
  Irony I, Parks MH, Meyer RJ. Irony I, et al. N Engl J Med. 2007 May 24;356(21):2221; author reply 2222-3. N Engl J Med. 2007. PMID: 17526095 No abstract available.
• New treatments for diabetes.
  Raz I, Eldor R. Raz I, et al. N Engl J Med. 2007 May 24;356(21):2222; author reply 2222-3. N Engl J Med. 2007. PMID: 17526096 No abstract available.

Similar articles

• Sitagliptin: a viewpoint by Mark S. Kipnes.
  Kipnes MS. Kipnes MS. Drugs. 2007;67(4):598-9. doi: 10.2165/00003495-200767040-00009. Drugs. 2007. PMID: 17352517 No abstract available.
• Sitagliptin (Januvia) for type 2 diabetes.
  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2007 Jan 1;49(1251):1-3. Med Lett Drugs Ther. 2007. PMID: 17179897 No abstract available.
• New treatments for diabetes.
  Bloomgarden ZT, Inzucchi SE. Bloomgarden ZT, et al. N Engl J Med. 2007 May 24;356(21):2219-20; author reply 2222-3. doi: 10.1056/NEJMc070546. N Engl J Med. 2007. PMID: 17522409 No abstract available.
• Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes.
  Deacon CF. Deacon CF. Expert Opin Investig Drugs. 2007 Apr;16(4):533-45. doi: 10.1517/13543784.16.4.533. Expert Opin Investig Drugs. 2007. PMID: 17371200 Review.
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
  Drucker DJ, Nauck MA. Drucker DJ, et al. Lancet. 2006 Nov 11;368(9548):1696-705. doi: 10.1016/S0140-6736(06)69705-5. Lancet. 2006. PMID: 17098089 Review.

Cited by

• Diabetes Mellitus and Its Influence on Oral Health: Review.
  Alqadi SF. Alqadi SF. Diabetes Metab Syndr Obes. 2024 Jan 8;17:107-120. doi: 10.2147/DMSO.S426671. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38222034 Free PMC article. Review.
• The role of autophagy in the treatment of type II diabetes and its complications: a review.
  Zhao X, Bie LY, Pang DR, Li X, Yang LF, Chen DD, Wang YR, Gao Y. Zhao X, et al. Front Endocrinol (Lausanne). 2023 Sep 21;14:1228045. doi: 10.3389/fendo.2023.1228045. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37810881 Free PMC article. Review.
• Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers.
  Saiz-Rodríguez M, Ochoa D, Zubiaur P, Navares-Gómez M, Román M, Camargo-Mamani P, Luquero-Bueno S, Villapalos-García G, Alcaraz R, Mejía-Abril G, Santos-Mazo E, Abad-Santos F. Saiz-Rodríguez M, et al. J Pers Med. 2023 Mar 8;13(3):489. doi: 10.3390/jpm13030489. J Pers Med. 2023. PMID: 36983671 Free PMC article.
• Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.
  Vohra M, Sharma AR, Mallya S, Prabhu NB, Jayaram P, Nagri SK, Umakanth S, Rai PS. Vohra M, et al. J Endocrinol Invest. 2023 Jun;46(6):1205-1218. doi: 10.1007/s40618-022-01989-y. Epub 2022 Dec 18. J Endocrinol Invest. 2023. PMID: 36528847 Free PMC article.
• The Molecular Effects of SGLT2i Empagliflozin on the Autophagy Pathway in Diabetes Mellitus Type 2 and Its Complications.
  Saad R, Tadmor H, Ertracht O, Nakhoul N, Nakhoul F, Evgeny F, Atar S. Saad R, et al. J Diabetes Res. 2022 Oct 19;2022:8337823. doi: 10.1155/2022/8337823. eCollection 2022. J Diabetes Res. 2022. PMID: 36313818 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal